IIL - Intravenous Infusions Limited
Intravenous Infusions Limited (IIL) is a Ghanaian pharmaceutical company and the market leader in the manufacture of intravenous infusions in the country. IIL was incorporated in 1969 and began operations in 1974 as the first pharmaceutical company producing intravenous infusions in Ghana. The company was set up to take advantage of the total lack of local production of infusions and the country's dependence on imports. Since then, IIL has grown to become the dominating market leader with a market share of about 50% in the country. The company also exports its products to the immediate neighboring countries, namely, Ivory Coast, Burkina Faso, and Togo. Intravenous Infusions Limited listed on the Ghana Alternative Market in December 2015.
|Last Trading Results||Growth & Valuation|
|Opening Price:||--||Earnings Per Share:||0.0120|
|Day's Low Price:||--||Price/Earning Ratio:||6.64|
|Day's High Price:||--||Dividend Per Share:||0.00|
|Traded Volume:||0||Dividend Yield:||0%|
|Number of Deals:||0||Shares Outstanding:||258.82m|
IIL Stock Market Performance
The stock of Intravenous Infusions Limited (IIL) is currently trading at 0.08 GHS per share on the Ghana Stock Exchange. The table below details the last 10 trading days of activity of Intravenous Infusions Limited on the Ghana Stock Exchange.
Profile of Intravenous Infusions Limited
Intravenous Infusions Limited operates in the Health Care sector. Unfortunately, we do not have information on the company's board of directors and/or key executives at this time.
|Factsheet of Intravenous Infusions Limited|
Plot 4/7 BIKL, Adjacent Highways workshop, Akwadum Road, Effiduase-Koforidua
IIL Industrial Market Competitors
Intravenous Infusions Limited, issuers of the IIL stock on the Ghana Stock Exchange, have two market competitors who are also engaged in the Health Care sector. The table below gives you an overview of their market standing.
|Code||Name||Mkt. Cap.||L. Price||YearTD|
|SPL||Starwin Products Limited||7.79m||0.03||+50.0%|
|AYRTN||Ayrton Drugs Manufacturing Co.||17.20m||0.08||+14.3%|